Alveogene is a startup based in the United Kingdom, most recent round Seed, 3 tracked investors.
Based in the United Kingdom, Alveogene is a startup. Its most recent tracked round is Seed. Brouky records 3 investors associated with the company.
Alveogene is developing inhaled gene therapies for rare respiratory diseases using a proprietary lentiviral delivery platform called InGenuiTy™, allowing efficient transduction of lung epithelial cells with long duration of action.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.